We don’t know the exact cause of autism – it has both environmental and genetic influences – but we do know that prevalence has increased tenfold in the past few decades, and that early intervention is critical for its treatment.
Key to early intervention, of course, is early diagnosis.
Boston-area startup SynapDx is developing a blood test to help diagnose autism, with aims to bring the age of diagnosis much lower than it is today. Its test, which identifies biomarkers that the company itself has found associated with autism, is meant to be given to kids who are showing symptoms of an autism spectrum disorder.
“Our idea was to create a simple blood test to look at markers in the blood associated with autism, but not with other developmental disorders,” CEO Stanley Lapidus said. Continue